Symrise (SYIEY)
(Delayed Data from OTC)
$34.00 USD
-0.25 (-0.73%)
Updated Sep 26, 2024 03:54 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
SYIEY 34.00 -0.25(-0.73%)
Will SYIEY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SYIEY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SYIEY
Is Keurig Dr Pepper (KDP) Stock Outpacing Its Consumer Staples Peers This Year?
Are Consumer Staples Stocks Lagging Danone (DANOY) This Year?
SYIEY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Consumer Staples Stocks Lagging Ollie's Bargain Outlet (OLLI) This Year?
All You Need to Know About Symrise AG Unsponsored ADR (SYIEY) Rating Upgrade to Strong Buy
Are Beauty Stocks Really Recession-Proof, or Even Recession-Resistant?
Other News for SYIEY
DSM-Firmenich: Making Progress, Still Far From Delivering On Its Full Potential
GLOBAL BROKER RATINGS: Jefferies raises BASF, JPMorgan cuts Moderna
GLOBAL BROKER RATINGS: Warburg raises BMW; BofA cuts Novartis
Symrise price target raised by EUR 15 at Morgan Stanley
GLOBAL BROKER RATINGS: Goldman ups Symrise; BofA raises Bayer